Title of article
Capecitabine Induced Multifocal Leukoencephalopathy:Do We Have Always to Switch off the Chemotherapy ?
Author/Authors
Andreadou, Elisabeth Department of Neurology - National and Kapodistrian University of Athens Medical School - Eginition Hospital - Athens, Greece , Bougea, Anastasia Department of Neurology - National and Kapodistrian University of Athens Medical School - Eginition Hospital - Athens, Greece , Voskou, Panagiota Department of Neurology - National and Kapodistrian University of Athens Medical School - Eginition Hospital - Athens, Greece , Kilidireas, Constantinos Department of Neurology - National and Kapodistrian University of Athens Medical School - Eginition Hospital - Athens, Greece
Pages
4
From page
1
To page
4
Abstract
Capecitabine is a well tolerated and safe 5-fluorouracil agent for adjuvant, neoadjuvant chemotherapy or metastatic cases.Neurological side effects require discontinuation of chemotherapy. We report this unique case of a 50-year-old female, whopresented an isolated episode of dysarthria and ataxia under bevacizumab, capecitabine, and oxaliplatin treatment due to reversiblemultifocal leukoencephalopathy that did not recur after readministration of chemotherapy
Keywords
Capecitabine Induced Multifocal Leukoencephalopathy , Switch off the Chemotherapy , 5-Fluorouracil (5-FU)
Journal title
Case Reports in Oncological Medicine
Serial Year
2016
Record number
2612047
Link To Document